Table 3.
Item | Treatments1 |
||||||
---|---|---|---|---|---|---|---|
NC | PC | COS | PRO | CPRO | SEM | P-value | |
PUN, mmol/L | |||||||
0 h | 1.92 | 1.58 | 1.10 | 1.77 | 1.30 | 0.33 | 0.526 |
24 h | 2.97 | 2.23 | 3.22 | 2.38 | 3.23 | 0.46 | 0.530 |
48 h | 2.87 | 2.02 | 2.62 | 2.37 | 2.55 | 0.46 | 0.821 |
VH, μm | 283.8 | 359.7 | 320.3 | 310.3 | 301.0 | 17.72 | 0.099 |
CD, μm | 262.5 | 206.7 | 260.0 | 254.0 | 247.5 | 17.22 | 0.253 |
VH:CD | 1.07b | 1.76a | 1.28b | 1.24b | 1.25b | 0.09 | 0.001 |
VH = villus height; CD = crypt depth; VH:CD = villus: crypt ratio; SEM = standard error of the mean.
a,b Values within a row with different letters are significantly different (P < 0.05).
NC = negative control; PC = positive control, NC + 2.5 g chlortetracycline/kg feed; COS = NC + 400 mg COS/kg feed (inclusion rate of COS was determined based on manufacturer's recommendations and previous studies such as Xu et al., 2013, Xu et al., 2014, Xiao et al., 2014); PRO = NC + 100 mg Enterococcus faecalis CG1.0007 probiotic (1.0 × 1010 cfu/g microcapsules)/kg feed (inclusion rate of probiotic was determined based on manufacturer's recommendations and previous studies such as Han et al., 2013); CPRO = NC + 400 mg COS/kg feed and 100 mg Enterococcus faecalis CG1.0007 probiotic (microcapsules)/kg feed.